DK0414475T3 - Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier - Google Patents

Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier

Info

Publication number
DK0414475T3
DK0414475T3 DK90309120.5T DK90309120T DK0414475T3 DK 0414475 T3 DK0414475 T3 DK 0414475T3 DK 90309120 T DK90309120 T DK 90309120T DK 0414475 T3 DK0414475 T3 DK 0414475T3
Authority
DK
Denmark
Prior art keywords
methods
cell lines
lymphocyte cell
culturing hcv
hcv
Prior art date
Application number
DK90309120.5T
Other languages
English (en)
Inventor
Amy J Weiner
Kathelyn S Steimer
Michael Houghton
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23576300&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0414475(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of DK0414475T3 publication Critical patent/DK0414475T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24221—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
DK90309120.5T 1989-08-25 1990-08-21 Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier DK0414475T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39866789A 1989-08-25 1989-08-25

Publications (1)

Publication Number Publication Date
DK0414475T3 true DK0414475T3 (da) 1998-02-09

Family

ID=23576300

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90309120.5T DK0414475T3 (da) 1989-08-25 1990-08-21 Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier

Country Status (12)

Country Link
EP (1) EP0414475B1 (da)
JP (3) JPH05502156A (da)
AT (1) ATE161041T1 (da)
AU (1) AU655156B2 (da)
CA (1) CA2064705C (da)
DE (1) DE69031791T2 (da)
DK (1) DK0414475T3 (da)
ES (1) ES2110411T3 (da)
GR (1) GR3026114T3 (da)
IE (1) IE903097A1 (da)
PT (1) PT95093B (da)
WO (1) WO1991002820A1 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2029171A6 (es) 1989-12-18 1992-07-16 Wellcome Found Un procedimiento para preparar un polipeptido virico de hepatitis no a y no b post-transfusional (pt-nanbh)
US7166287B1 (en) 1989-12-18 2007-01-23 Glaxo Wellcome Inc. Viral agent
AU7672991A (en) * 1990-04-03 1991-10-30 Southwest Foundation For Biomedical Research Purified hcv and hcv proteins and peptides
WO1991015596A1 (en) * 1990-04-04 1991-10-17 Protos, Inc. Hepatitis c virus protease inhibitors
EP1018558A3 (en) * 1990-04-06 2002-06-05 Genelabs Technologies, Inc. Hepatitis C Virus Epitopes
US5747339A (en) * 1990-06-25 1998-05-05 Research Foundation For Microbial Diseases Of Osaka Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
EP0516270A3 (en) * 1991-04-10 1993-06-23 Immuno Japan Inc. Non-a, non-b hepatitis virus related antigen, antibody, detection systems, polynucleotides and polypeptides
US5428145A (en) * 1991-08-09 1995-06-27 Immuno Japan, Inc. Non-A, non-B, hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody and detection systems
JP3688290B2 (ja) * 1991-11-21 2005-08-24 コモン サーヴィシス エージェンシー Ｃ型肝炎ウイルス検査
US5552310A (en) * 1992-06-12 1996-09-03 Hiroshi Yoshikura Replication of hepatitis C virus genome and identification of virus having high infectivity
WO1994025064A1 (en) * 1993-05-04 1994-11-10 THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMANSERVIC ES Hepatitis c virus cell propagation and related methods
US5840565A (en) 1995-08-22 1998-11-24 The Regents Of The University Of California Methods for enhancing the production of viral vaccines in PKR-deficient cell culture
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US5851758A (en) * 1995-10-25 1998-12-22 Childrens Research Institute Cytopathic replication of hepatitis C virus in a new cell line
ES2175355T3 (es) * 1996-01-29 2002-11-16 Virologic Inc Composiciones y metodos para determinar la susceptibilidad y la resistencia a farmacos antivirales y rastreo de farmacos antivirales.
US6242187B1 (en) 1996-01-29 2001-06-05 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
WO1998021338A1 (en) 1996-11-08 1998-05-22 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Synthesis and purification of hepatitis c virus-like particles
US7049428B1 (en) 1998-03-04 2006-05-23 Washington University HCV variants
US7338759B1 (en) 1997-03-04 2008-03-04 Washington University HCV variants
AT407256B (de) * 1998-06-24 2001-02-26 Immuno Ag Hepatitis c-virus positive endometriale zelllinie
US6680059B2 (en) 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US6858590B2 (en) 2000-08-17 2005-02-22 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
CA2419418A1 (en) 2000-08-17 2002-02-21 Tripep Ab Vaccines containing ribavirin and methods of use thereof
WO2007031867A2 (en) 2005-05-25 2007-03-22 Tripep Ab A hepatitis c virus non-stru tural ns3/4a fusion gene
US8071561B2 (en) 2007-08-16 2011-12-06 Chrontech Pharma Ab Immunogen platform
WO2009130588A2 (en) 2008-04-22 2009-10-29 Tripep Ab Immunogen platform
GB201119011D0 (en) * 2011-11-03 2011-12-14 Queen Mary Innovation Ltd Method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464474A (en) * 1980-07-09 1984-08-07 Connaught Laboratories Limited Non-A, non-B hepatitis assay and vaccine
EP0071640B1 (en) * 1981-02-11 1986-06-04 Connaught Laboratories Incorporated Non-a, non-b hepatitis virus
WO1987005930A1 (en) * 1986-04-01 1987-10-08 Genelabs Incorporated Immortalized virus-specific tissue cells
CN1074422C (zh) * 1987-11-18 2001-11-07 希龙股份有限公司 制备含有hcv表位的分离多肽的方法

Also Published As

Publication number Publication date
EP0414475B1 (en) 1997-12-10
ATE161041T1 (de) 1997-12-15
JPH05502156A (ja) 1993-04-22
IE903097A1 (en) 1991-02-27
AU6344990A (en) 1991-04-03
JP2004049235A (ja) 2004-02-19
PT95093B (pt) 1997-11-28
PT95093A (pt) 1991-05-22
EP0414475A1 (en) 1991-02-27
CA2064705C (en) 1999-04-06
ES2110411T3 (es) 1998-02-16
DE69031791D1 (de) 1998-01-22
DE69031791T2 (de) 1998-04-02
AU655156B2 (en) 1994-12-08
CA2064705A1 (en) 1991-02-26
GR3026114T3 (en) 1998-05-29
JP2001314192A (ja) 2001-11-13
WO1991002820A1 (en) 1991-03-07

Similar Documents

Publication Publication Date Title
DK0414475T3 (da) Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier
YU45871B (sh) Polipeptid sa humanim imunointerferonskim (ifn-gama) svojstvima
DK0451611T3 (da) Human hæmatopoietisk stamcelle
DK0891420T3 (da) Fremgangsmåde til replikation af influenzavirus i cellekultur samt de ved fremgangsmåden opnåelige influenzavirus
ATE482267T1 (de) Tierzellen und verfahren für die replikation von influenza viren
ATE161040T1 (de) Kultivierung von vero-zellen
DE69534595D1 (de) Methode zur proliferation und differenzierung von b-zellen und verwendungen dafür
ATE301707T1 (de) Aus einer mit einem stamm von multiple-sklerosis- virus infizierten zellinie hergestelltes biologisches virusmaterial
ATE114713T1 (de) Biomasse zur produktion von virus/virusantigen.
DK372780A (da) Fremgangsmaade til propagering af humant hepatitis a virus
ATE530657T1 (de) Verfahren zur herstellung von zellinien mit latentem immunschwächevirus
ES8104405A1 (es) Procedimiento para preparar una vacuna de virus de gripe
DK0658626T3 (da) Fremgangsmåder til produktion af protein C
DK0651788T3 (da) Fremgangsmåde til dyrkning af en celletype i en cokulturfremgangsmåde med leverceller
DK439086A (da) Fremgangsmaader til anvendelse af cellelinier, der mangler humane klasseii histokompatibilitetsantigener
DK713188A (da) Fremgangsmaade til fremstilling af pregneno-oxazoliner
DK0485504T3 (da) Fremgangsmåde til fremstilling af aktiveret protein C ved celledyrkning
DK628188A (da) Protein og fremgangsmaade til fremstilling deraf
FR2585722B1 (fr) Co-cultures d'hepatocytes et de cellules epitheliales de foie traitees
DK204586D0 (da) Hybridceller, der producerer et karakteristisk antigen for hepatitis b-virus, opnaaet ud fra hepatocytter og celler, der er tilvejebragt fra aber, fremgangsmaade til opnaaelse af hybridcellerne og anvendelse af disse til produktion af antigenet
DK107493A (da) Vektor for udtrykkelse i gaer, bestaaende af et fremmed dna-segment og en fremgangsmaade til syntese af fremmede proteiner ved hjaelp af en saadan vektor